IP Library Granted Patent US 7,790,095
Granted Patent B2
US 7,790,095 · App. 11/948,393 · Granted Sep 7, 2010

Methods for making oxidation resistant polymeric material

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,790,095
App. No.
11/948,393
Granted
Sep 7, 2010
Kind
B2
Abstract

The present invention relates to methods for making oxidation resistant medical devices that comprise polymeric materials, for example, ultra-high molecular weight polyethylene (UHMWPE). The invention also provides methods of making antioxidant-doped medical implants, for example, doping of medical devices containing cross-linked UHMWPE with vitamin E by diffusion and materials used therein.

Claims (53)

1. A method of making an oxidation and wear resistant ultrahigh molecular weight polyethylene (UHMWPE) for use in a medical implant, wherein the method comprises:

(a) providing consolidated and cross-linked UHMWPE that has been irradiated with ionizing radiation;

(b) doping the consolidated and cross-linked UHMWPE with an antioxidant by diffusion, thereby allowing formation of a gradient of an antioxidant in the consolidated and cross-linked UHMWPE; and

(c) annealing the consolidated and cross-linked UHMWPE at a temperature below its melting point to increase uniformity of antioxidant distribution in the consolidated and cross-linked UHMWPE such that the antioxidant can react with free radicals throughout the consolidated and cross-linked UHMWPE,

wherein the method provides a consolidated and cross-linked UHMWPE that is oxidation and wear resistant and can be used in a medical implant.

2. The method of claim 1 , wherein the doping is carried out by soaking the consolidated and cross-linked UHMWPE in an antioxidant for about an hour to about 16 hours.

3. The method of claim 1 , wherein the doping is carried out by diffusion with an antioxidant in a supercritical fluid.

4. The method of claim 3 , wherein the supercritical fluid is CO 2 .

5. The method of claim 1 , wherein the antioxidant is heated to about 100° C. or more and the doping is carried out at 100° C. or more.

6. The method of claim 1 , wherein the antioxidant is selected from the group consisting of:

Alpha-tocopherol, delta-tocopherol,

propyl gallates, octyl gallates, dedocyl gallates,

lactic acids, citric acids, tartaric acids, or any salt thereof,

orthophosphates, and

tocopherol acetate.

7. The method of claim 1 , wherein the antioxidant is vitamin E.

8. A method of making a medical implant comprising oxidation and wear resistant ultrahigh molecular weight polyethylene (UHMWPE), wherein the method comprises:

(a) providing consolidated and cross-linked UHMWPE that has been irradiated with ionizing radiation;

(b) doping the consolidated and cross-linked UHMWPE with an antioxidant by diffusion, thereby allowing formation of a gradient of an antioxidant in the consolidated and cross-linked UHMWPE;

(c) annealing the consolidated and cross-linked UHMWPE at a temperature below its melting point to increase uniformity of antioxidant distribution in the consolidated and cross-linked UHMWPE such that the antioxidant can react with free radicals throughout the consolidated and cross-linked UHMWPE, and

(d) machining the consolidated and cross-linked UHMWPE, thereby forming the medical implant comprising oxidation and wear resistant UHMWPE.

9. The method of claim 8 , wherein the medical implant is packaged and sterilized by ionizing radiation or gas sterilization.

10. The method of claim 8 , wherein the doping is carried out by soaking the consolidated and cross-linked UHMWPE in an antioxidant for about an hour to about 16 hours.

11. The method of claim 8 , wherein the antioxidant is heated to about 100° C. or more and the doping is carried out at 100° C. or more.

12. The method of claim 8 , wherein the doping is carried out by diffusion with an antioxidant in a supercritical fluid.

13. The method of claim 11 , wherein the supercritical fluid is CO 2 .

14. The method of claim 8 , wherein the antioxidant is selected from the group consisting of:

Alpha-tocopherol, delta-tocopherol,

propyl gallates, octyl gallates, dedocyl gallates,

lactic acids, citric acids, tartaric acids, or any salt thereof,

orthophosphates, and

tocopherol acetate.

15. The method of claim 8 , wherein the antioxidant is vitamin E.

16. The method according to claim 8 , wherein the medical implant forms all or part of one selected from the group consisting of acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint component, bipolar hip replacements, tibial knee insert, tibial knee inserts with reinforcing metallic and polyethylene posts, intervertebral discs, sutures, tendons, heart valves, stents, and vascular grafts.

17. A method of making an interlocked hybrid medical device comprising oxidation and wear resistant ultrahigh molecular weight polyethylene (UHMWPE), wherein the method comprises:

(a) providing consolidated and cross-linked UHMWPE that has been irradiated with ionizing radiation;

(b) doping the consolidated and cross-linked UHMWPE with an antioxidant by diffusion, thereby allowing formation of a gradient of an antioxidant in the consolidated and cross-linked UHMWPE;

(c) annealing the consolidated and cross-linked UHMWPE at a temperature below its melting point to increase uniformity of antioxidant distribution in the consolidated and cross-linked UHMWPE such that the antioxidant can react with free radicals throughout the consolidated and cross-linked UHMWPE;

d) compression molding the antioxidant-doped UHMWPE to the counter face of a metallic material, thereby forming an interlocked hybrid material having an interface between the antioxidant-doped UHMWPE and the metallic material; and

e) machining the interlocked hybrid material to form the interlocked hybrid medical device having the oxidation and wear resistant UHMWPE.

18. The method of claim 17 further comprising packaging and sterilizing the packaged medical device by ionizing radiation or gas sterilization, thereby forming a sterile interlocked hybrid medical device comprising oxidation and wear resistant UHMWPE.

19. The method of claim 17 , wherein the doping is carried out by soaking the consolidated and cross-linked UHMWPE in an antioxidant for about an hour to about 16 hours.

20. The method of claim 17 , wherein the antioxidant is heated to about 100° C. or more and the doping is carried out at 100° C. or more.

21. The method of claim 17 , wherein the doping is carried out by diffusion with an antioxidant in a supercritical fluid.

22. The method of claim 21 , wherein the supercritical fluid is CO 2 .

23. The method of claim 17 , wherein the antioxidant is selected from the group consisting of:

Alpha-tocopherol, delta-tocopherol,

propyl gallates, octyl gallates, dedocyl gallates,

lactic acids, citric acids, tartaric acids, or any salt thereof,

orthophosphates, and

tocopherol acetate.

24. The method of claim 17 , wherein the antioxidant is vitamin E.

25. The method according to claim 17 , wherein the medical device forms all or part of one selected from the group consisting of acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint component, bipolar hip replacements, tibial knee insert, tibial knee inserts with reinforcing metallic and polyethylene posts, intervertebral discs, sutures, tendons, heart valves, stents, and vascular grafts.

Assignments (4)
SECURITY AGREEMENT Recorded Sep 12, 2011
From: CAMBRIDGE POLYMER GROUP, INC.
To: BELMONT SAVINGS BANK
Reel/Frame 026890/0272 →
CHANGE OF NAME Recorded Jul 27, 2010
From: MASSACHUSETTS GENERAL HOSPITAL
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 024745/0410 →
CHANGE OF ADDRESS Recorded Jul 27, 2010
From: CAMBRIDGE POLYMER GROUP, INC.
To: CAMBRIDGE POLYMER GROUP, INC.
Reel/Frame 024745/0544 →
SECURITY AGREEMENT Recorded Dec 22, 2009
From: CAMBRIDGE POLYMER GROUP, INC.
To: RBS CITIZENS, N.A. SUCCESSOR BY MERGER WITH CITIZENS BANK OF MASSACHUSETTS
Reel/Frame 023691/0236 →